Skip to content

Entry verification

You are about to enter a research catalogue.

Compounds shown on this site are sold strictly for laboratory and research use. They are not licensed medicines and are not intended for human or veterinary consumption. UK 18+ verification is required to enter.

Date of birth

Date of birth (day, month, year)
I do not qualify · leave the site

MHRA · ASA · ICO · UK GDPR aware

Amber-glass lyophilised vial of TB-500 with white flip-cap and Optimal Lab cream-stripe label
fig. tb-500 · 10mg · LYOPHILISEDJanoshik-tested
Structural Peptides

TB-500

Synthetic 17-amino-acid fragment of thymosin β4. Reviewed across preclinical regenerative models and early-phase trials in ischaemic injury.[1,2]

Variants
Select variant size
Quantity
1

PayPal or cash on collection · UK 18+ verification at dispatch · For laboratory research use only

HPLC chromatogram

Reverse-phase trace

Single peak at the expected retention time. Area % integration shown on every lot record. Per-lot chromatogram available on request from our supplier, Janoshik.

Reconstitution

Math, not dosing

For 10mg vial + 2 mL BAC water → concentration calculation on the dedicated calculator page. We provide research procedure only.

Selected research · TB-500

  1. [1]Goldstein AL, Hannappel E, Sosne G, Kleinman HK. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy.Review of thymosin β4 across regenerative animal models and early-phase human trials.PMID 22074294
  2. [2]Crockford D. (2007). Development of thymosin beta4 for treatment of patients with ischemic heart disease. Annals of the New York Academy of Sciences.Preclinical and early-clinical pipeline for thymosin β4 in cardiac injury.PMID 17567947

All references describe published research on the compound. They do not constitute clinical guidance or imply therapeutic benefit to any individual purchaser. For laboratory research use only.